Indiva Limited

NDVA

CA45580J1012

Pharmaceuticals

Market Closed - Toronto S.E. Other stock markets 11:46:12 30/05/2024 pm IST			5-day change	1st Jan Change
0.05 ^CAD	-9.09%		-23.08%	-47.37%

23/05	Transcript : Indiva Limited, Q1 2024 Earnings Call, May 23, 2024
23/05	Indiva Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Indiva Limited Provides Revenue Guidance for the Fourth Quarter 2020

November 26, 2020 at 05:30 pm IST

Indiva Limited announced that company expects revenue growth to accelerate significantly in fiscal fourth quarter of 2020.

Latest news about Indiva Limited

Transcript : Indiva Limited, Q1 2024 Earnings Call, May 23, 2024	23/05
Indiva Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	23/05	CI
Indiva Limited Provides Earnings Guidance for the Second Quarter of 2024	23/05	CI
Transcript : Indiva Limited, Q4 2023 Earnings Call, Apr 25, 2024	25/04
Indiva Limited Provides Earnings Guidance for the First Quarter and Fiscal Year 2024	25/04	CI
Indiva Limited Reports Earnings Results for the Full Year Ended December 31, 2023	25/04	CI
Indiva Limited cancelled the transaction announced on February 28, 2024	04/03	CI
Indiva Files Amended And Restated Offering Document And Announced Concurrent Private Placement Of Up To $4.3 Million	28/02	MT
Indiva Limited announced that it expects to receive CAD 4.312 million in funding	28/02	CI
Indiva Announces Private Placement Under The Listed Issuer Financing Exemption of Up To $4 Million	22/01	MT
Indiva Limited announced that it expects to receive CAD 4 million in funding	22/01	CI
Indiva Updates Q4 Revenue Guidance; Provides 2023 Highlights	04/01	MT
Indiva Limited Revises Revenue Guidance for the Fourth Quarter of 2023	04/01	CI
Indiva Narrows Q3 Loss, Revenue Rises; Provides Q4 Outlook	21/11	MT
Transcript : Indiva Limited, Q3 2023 Earnings Call, Nov 21, 2023	21/11
Indiva Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	21/11	CI
Indiva Limited Provides Revenue Guidance for Fourth Quarter of 2023	21/11	CI
Indiva Limited Announces the Revenue Guidance for Third Quarter of 2023	29/23/29	CI
Indiva Posts Q2 Net Loss, Revenue Declines YOY	29/23/29	MT
Transcript : Indiva Limited, Q2 2023 Earnings Call, Aug 29, 2023	29/23/29
Indiva Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	29/23/29	CI
Indiva Limited Launches No Future Gummies and Vapes	10/23/10	CI
Transcript : Indiva Limited - Shareholder/Analyst Call	19/23/19
Indiva Brief: SNDL Inc. Says Between June 10, 2023, and June 22, 2023, It Disposed of 3,297,000 Common Shares In the Capital of Indiva	22/23/22	MT
Canopy Growth and Indiva Brief: Announcing Closing of Private Placement	17/23/17	MT

Indiva Limited, through its indirect wholly owned subsidiary, Indiva Inc., is a Canada-based producer of cannabis servicing the medical and recreational markets. The Company is engaged in producing and selling cannabis products, including dried flower, extract, and edible products. It focuses on the production and processing of edible and extract cannabis products as well as packaging of edibles and extracts. Its brands include Pearls by Gron, Bhang Chocolate, Indiva Doppio Sandwich Cookies, Indiva 1432 Chocolate, and No Future Gummies and Vapes, as well as other Indiva branded extracts. Its products include edibles and capsules. Its edibles include Vanilla Double -Stuffed Chocolate Cookie, Fudge Double-Stuffed Chocolate Cookie, and Golden Vanilla Double Stuffed Cookie. It sells its cannabis products to consumers in the recreational market in the provinces of Ontario, British Columbia, Alberta, Quebec, Nova Scotia, Saskatchewan, Manitoba, New Brunswick, Prince Edward Island, Newfound.

Sector

Pharmaceuticals

Calendar

28/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
INDIVA LIMITED	-47.37%	7.15M
DONG-E-E-JIAO CO.,LTD.	+38.97%	6.09B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-22.28%	4.14B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+3.48%	3.23B
TASLY PHARMACEUTICAL GROUP CO., LTD	-19.51%	2.83B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-7.29%	2.39B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+42.43%	1.9B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-4.71%	1.57B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-15.15%	1.55B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-14.86%	1.5B

Alternative Medicine

Indiva Limited

Equities

NDVA

CA45580J1012

Pharmaceuticals

Indiva Limited Provides Revenue Guidance for the Fourth Quarter 2020

Latest news about Indiva Limited

Chart Indiva Limited

Company Profile

Income Statement Evolution

Quarterly earnings - Rate of surprise

Sector Alternative Medicine